Loading...
Images of Akito Hata
(0 from 0 )Business Profiles
Researchgate: Akito Hata
Kobe, Japan
Books & Literature
外文检索-中国知网
scholar.cnki.net
CNKI学术搜索是一个基于海量资源的跨学科、跨语种、跨文献类型的学术资源搜索平台,其资源库涵盖各类学术期刊、论文、报纸、专利、标准、年鉴、工具书等,旨在为国内外研究人员提供全面、权威、系统的知识网络。
- مقالات نوشته شده توسط Akito Hata سایپرز، باشگاه دانش
www.scipers.com
رایگان و نامحدود به منابع بین المللی مقالات ژورنال (ISI) و کتاب های الکترونیکی (ایبوک)، مشاهده ترجمه چکیده مقاله و تبادل نظر با استادان و دانشجویان سراسر کشور با ...
authors:"Akito Hata" - Search | Paperity
paperity.org
Paperity: the 1st multidisciplinary aggregator of Open Access journals & papers. Free fulltext PDF articles from hundreds of disciplines, all in one place
AACR Proceedings: Abstracts Google Books Result
books.google.co.uk
... Daisuke Tomita, Jun Fujimoto, Osamu Kurasawa, Chisato Takahara, Ayumi Kawamura, Ryuichi Nishigaki, Yoshinori Satomi, Akito Hata, Takahito Hara.
Related Documents
CiteSeerX — RESEARCH ARTICLE Open Access
citeseerx.ist.psu.edu
BibTeX @MISC{Fujita_researcharticle, author = {Shiro Fujita and Katsuhiro Masago and Yukimasa Hatachi and Akiko Fukuhara and Akito Hata and Reiko Kaji and Young Hak
Panitumumab Rechallenge in Chemorefractory Patients with Metastatic...
www.deepdyve.com
CASE REPORT. Panitumumab Rechallenge in Chemorefractory Patients. with Metastatic Colorectal Cancer. Akito Hata. &. Nobuyuki Katakami.
Nozomu Nozomi - PDF documents
www.documbase.com
Nozomu sugiyama environment art leads junko tsuji kai shibusawa user interface design lead... nozomi furuta machiko hara environment art...
Scientific Publications
Does afatinib plus bevacizumab combination therapy induce positive...
www.ncbi.nlm.nih.gov
Akito Hata received lecture fees from Chugai, Astra Zeneca, Boehringer Ingelheim, and Eli Lilly. Dr. Katakami received grants from Astra ...
Genetic polymorphisms in the endothelial nitric oxide synthase gene...
bmcmedgenet.biomedcentral.com
Shiro Fujita *, Katsuhiro Masago, Yukimasa Hatachi, Akiko Fukuhara, Akito Hata, Reiko Kaji, Young Hak Kim, Tadashi Mio, Michiaki Mishima and Nobuyuki Katakami
Akito Hata – ScienceOpen
www.scienceopen.com
The secondary epidermal growth factor receptor (EGFR) mutation Thr790Met (T790M) accounts for approximately half of acquired resistances to EGFR-tyrosine ...
Weekly administration of paclitaxel and carboplatin with concurrent...
www.ncbi.nlm.nih.gov
Jan 27, · jumpei takeshita, 1 katsuhiro masago, 1 shiro fujita, 1 akito hata, 1 reiko kaji, 1 takahisa kawamura, 2 koji tamai, 2 takeshi matsumoto, 2 kazuma nagata
Publications
A phase II study of pemetrexed monotherapy in chemo-naïve Eastern...
link.springer.com
* Akito Hata 1 Division of Integrated Oncology, Institute of Biomedical Research and Innovation, 2-2, Minatojima-minamimachi,
Akito Hata's Research | CureHunter
www.curehunter.com
Akito Hata Selected Research. Akito Hata Research Topics Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Neoplasms (Cancer)
Oalib search
www.oalib.com
Shiro Fujita, Katsuhiro Masago, Yukimasa Hatachi, Akiko Fukuhara, Akito Hata, Reiko Kaji, Young Kim, Tadashi Mio, Michiaki Mishima, ...
Miscellaneous
Researcher: Akito Hata in Publications - Dimensions
app.dimensions.ai
Kei Irie, Akira Okada, Yoshio Masuda, Keizo Fukushima, Nobuyuki Sugioka, Chiyuki Okuda, Akito Hata, Reiko Kaji, Yutaka Okada, Nobuyuki Katakami, Shoji ...
Akito Hata
www.infona.pl
A randomized phase II study of bevacizumab in combination with docetaxel or S- 1 in patients with non-squamous non-small-cell lung cancer ...
Keisuke Tomii - Publications List
publicationslist.org
Akito Hata, Nobuyuki Katakami, Shiro Fujita, Reiko Kaji, Yukihiro Imai, Yutaka Takahashi, Takashi Nishimura, Keisuke Tomii, Kyosuke Ishihara Frequency of EGFR and KRAS mutations in Japanese patients with lung adenocarcinoma with features of the mucinous subtype of bronchioloalveolar carcinoma.
A multi-center, Phase II trial of nab-paclitaxel and gemcitabine ...
www.dovepress.com
Motoko Tachihara,1 Tatsunori Kiriu,1Akito Hata,2 Yukihisa Hatakeyama,3 Kyosuke Nakata,1 Tatsuya Nagano,1 Masatsugu Yamamoto,1 ...
Oncotarget | Docetaxel plus ramucirumab with primary prophylactic...
www.oncotarget.com
Oncotarget | https://doi.org oncotarget Akito Hata, Daijiro Harada, Chiyuki Okuda, Reiko Kaji, Yoshio Masuda, Yoshika Takechi, Toshiyuki Kozuki,...
Afatinib (AFA) plus Bevacizumab (BEV) Combination after ...
oncologypro.esmo.org
Topics, Immunotherapy. Presenter, Akito Hata. Citation, Annals of Oncology (2018) 29 (suppl_8): viii493-viii annonc/mdy292.
Amrubicin at a lower-dose with routine prophylactic use of...
www.infona.pl
Akito Hata. Division of Integrated Oncology, Institute of Biomedical Research and Innovation, 2-2, Minatojima-minamimachi, Chuo-ku, Kobe , Japan.
Biomedical Reports - Spandidos Publications
www.spandidos-publications.com
... errors in whole exome sequencing using the Ion Proton System. Shiro Fujita, Katsuhiro Masago, Chiyuki Okuda, Akito Hata, Reiko Kaji, Nobuyuki Katakami, ...
AMERICAN JOURNAL OF ROENTGENOLOGY. CT-Guided Fine-Needle Aspiration...
servei.org
Just another WordPress site
Design and synthesis of selective CDK8/19 dual inhibitors: Discovery...
www.x-mol.com
X-MOL提供的期刊论文更新,Bioorganic & Medicinal Chemistry——Design and synthesis of selective CDK8/19 dual inhibitors: Discovery of...
Identification of Novel, Potent, and Orally Available Figshare
figshare.com
Akito Hata, Asano Akito Nakamura Tadahiro Nambu Akito Hata Tsuyoshi Ishii Tomoya Sameshima Yasuyuki Debori Maki Miyamoto Michael ...
Bevacizumab for critical brain metastases in a patient with pulmonary...
read.qxmd.com
Bevacizumab for critical brain metastases in a patient with pulmonary pleomorphic carcinoma. Akito Hata, Shiro Fujita, Kenji Takayama, Nobuyuki Katakami.
Magnesium intake decreases Type 2 diabetes risk through the...
kyushu-u.pure.elsevier.com
... diabetes risk through the improvement of insulin resistance and inflammation: The Hisayama Study. Akito Hata, Y. Doi, Toshiharu Ninomiya, ...
Altmetric – Next-generation sequencing of tyrosine kinase...
www.altmetric.com
Katsuhiro Masago, Shiro Fujita, Miho Muraki, Akito Hata, Chiyuki Okuda, Kyoko Otsuka, Reiko Kaji, Jumpei Takeshita, Ryoji Kato, Nobuyuki ...
Multiple primary malignancies in Japanese patients with non ...
erj.ersjournals.com
Shiro Fujita, Junpei Takeshita, Kosuke Tanaka, Akito Hata, Katsuhiro Masago, Reiko Kaji, Kenji Takayama, Masaki Kokubo, Nobuyuki Katakami. European ...
Pembrolizumab + Platinum Doublets Without Radiation for ...
clinicaltrials.gov
Responsible Party: Akito Hata, Akito Hata, Director of Division of Thoracic Oncology, Kobe Minimally Invasive Cancer Center. ClinicalTrials.gov ...
Multiple primary malignancies in Japanese patients with non-small...
erj.ersjournals.com
Akito Hata 1, Katsuhiro Masago 1, Reiko Kaji 1, Kenji Takayama 2, Masaki Kokubo 2 and Nobuyuki Katakami 1; 1 Division of Integrated Oncology, Institute
[PDF] Genetic polymorphisms in the endothelial nitric oxide synthase...
www.semanticscholar.org
treated with platinum-based doublet chemotherapy. Authors: Shiro Fujita (). Katsuhiro Masago (-u.ac.jp). Yukimasa Hatachi (-u.ac.jp). Akiko Fukuhara (-u.ac.jp). Akito Hata (). Reiko Kaji ().
Cytokeratin 19 fragment predicts the efficacy of epidermal growth...
read.qxmd.com
Kosuke Tanaka, Akito Hata, Reiko Kaji, Shiro Fujita, Takehiro Otoshi, Daichi Fujimoto, Takahisa Kawamura, Koji Tamai, Jumpei Takeshita, Takeshi Matsumoto, ...
Dose reduction or intermittent administration of erlotinib: which is ...
www.galenicom.com
Authors. Akito Hata · Shiro Fujita · Reiko Kaji · Shigeki Nanjo · Nobuyuki Katakami. Publication date Journal. Internal medicine. Intern Med ...
Related search requests for Akito Hata
Akiko Fukuhara Kenji Takayama Takashi Nishimura | Shiro Fujita Reiko Kaji Naoto Kitajima | Meiko Kaji |
People Forename "Akito" (120) Name "Hata" (405) |
sorted by relevance / date